Enteric fever treatment
Reading File
Now I'll search the medical library and PubMed in parallel for enteric fever treatment.
Finding Sources
Finding Sources
Searching PubMed
"enteric fever" AND treatment
Good results found. Let me read the key sections from Harrison's (2025) and Jawetz for detailed treatment content.
Reading File
Reading File
Reading File
I have good detail from Harrison's and Jawetz. Let me now read the full Harrison's treatment section and the Fitzpatrick's medications section for more comprehensive coverage.
Reading File
Reading File
I have the full antibiotic table from Harrison's and supporting information. Let me compile a comprehensive answer now.
Enteric Fever - Treatment
Enteric fever (typhoid and paratyphoid fever) caused by Salmonella Typhi and Paratyphi carries a case-fatality rate of 2.5% overall, rising to 10-30% if untreated. Prompt antibiotic therapy reduces mortality to <1%.
Antibiotic Therapy (Harrison's, 22e, 2025)
Empirical Treatment
| Agent | Dose | Route | Duration |
|---|---|---|---|
| Ceftriaxone | 2 g/day | IV | 10-14 days |
| Ciprofloxacin^b^ | 500 mg BID | PO | 5-7 days |
| Azithromycin^c^ | 1 g/day | PO | 10 days |
Fully Susceptible Strains
| Agent | Dose | Route | Duration |
|---|---|---|---|
| Ceftriaxone (optimal) | 2 g/day | IV | 10-14 days |
| Ciprofloxacin (optimal) | 500 mg BID | PO / 400 mg q12h IV | 5-7 days |
| Azithromycin (alt) | 1 g/day | PO | 5 days |
| Amoxicillin (alt) | 1 g TID | PO / 2 g q6h IV | 14 days |
| Chloramphenicol (alt) | 25 mg/kg TID | PO or IV | 14-21 days |
| TMP-SMX (alt) | 160/800 mg BID | PO | 7-14 days |
Multidrug-Resistant (MDR) Strains
For MDR strains (resistant to ampicillin, TMP-SMX, chloramphenicol):
| Agent | Dose | Route | Duration |
|---|---|---|---|
| Ceftriaxone (optimal) | 2 g/day | IV | 10-14 days |
| Ciprofloxacin (optimal) | 500 mg BID | PO | 5-7 days |
| Azithromycin (optimal) | 1 g/day | PO | 10 days |
| Cefixime (alt) | 200 mg BID | PO | 10-14 days |
Decreased Fluoroquinolone Susceptibility (XDR strains)
Extensively drug-resistant (XDR) S. Typhi - resistant to fluoroquinolones, ampicillin, TMP-SMX, chloramphenicol, and third-generation cephalosporins:
| Agent | Dose | Route | Duration |
|---|---|---|---|
| Azithromycin (optimal) | 1 g/day | PO | 10 days |
| Carbapenem (e.g., meropenem) | Weight-based | IV | 10-14 days |
Key Clinical Points
Fluoroquinolone resistance: Due to high prevalence of strains with decreased ciprofloxacin susceptibility (MIC >0.125 μg/mL) on the Indian subcontinent and parts of Africa, fluoroquinolones are no longer first-line empirical therapy for travelers from these regions. Azithromycin or ceftriaxone are preferred.
Uncomplicated enteric fever: Can be managed outpatient with oral azithromycin (1 g once, then 500 mg daily for 7 days). - Jawetz Medical Microbiology, 28e
Complicated/Severe enteric fever: Hospitalize and treat with parenteral third-generation cephalosporin or fluoroquinolone for at least 10 days. - Jawetz, 28e
Cefixime (oral): Effective but may increase risk of clinical failure and prolong time to defervescence compared with fluoroquinolones; used when IV therapy not possible. - Harrison's 22e
A 2022 systematic review of 27 RCTs found no significant difference between ceftriaxone, fluoroquinolones, and azithromycin in treatment failure, microbiologic failure, relapse, or adverse events. - Harrison's 22e
Severe Complications - Additional Management
- Intestinal perforation / GI bleeding: Immediate fluid resuscitation + surgical intervention + broadened antibiotics for polymicrobial peritonitis. Mortality from ileal perforation: 10-32%.
- Severe enteric fever with altered consciousness: Dexamethasone (3 mg/kg IV loading dose, then 1 mg/kg q6h for 48 hours) reduces mortality. This remains one of the few indications for glucocorticoids in acute bacterial infection. Steroids beyond 48 hours may increase relapse rate. - Harrison's 22e
Chronic Carrier State
- 2-5% of patients develop chronic carriage (>1 year excretion in stool/urine), especially with biliary abnormalities or gallstones.
- Treatment: Ampicillin or fluoroquinolone for 4-6 weeks. Most cases require cholecystectomy combined with antibiotics for definitive cure. - Jawetz, 28e
Prevention
- Ty21a vaccine (oral, live attenuated) - also offers limited protection against S. Paratyphi A and B.
- Vi polysaccharide vaccine (parenteral) - effective against S. Typhi only; does not protect against paratyphoid (no Vi antigen).
- A newer typhoid conjugate vaccine (TCV) is now WHO-recommended for children in endemic areas and provides longer-lasting immunity.
Sources: Harrison's Principles of Internal Medicine 22e (2025), p. 1361 | Jawetz Melnick & Adelberg's Medical Microbiology 28e | Fitzpatrick's Dermatology, Vol. 1-2
This is a shared conversation. Sign in to Orris to start your own chat.